Illumina Shares Outstanding 2006-2018 | ILMN

Illumina shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Illumina shares outstanding for the quarter ending December 31, 2018 were 0.149B, a 0.68% increase year-over-year.
  • Illumina 2018 shares outstanding were 0.149B, a 0.68% increase from 2017.
  • Illumina 2017 shares outstanding were 0.148B, a 0% decline from 2016.
  • Illumina 2016 shares outstanding were 0.148B, a 0.67% decline from 2015.
Illumina Annual Shares Outstanding
(Millions of Shares)
2018 149
2017 148
2016 148
2015 149
2014 149
2013 140
2012 134
2011 139
2010 143
2009 137
2008 134
2007 108
2006 98
2005 80
Illumina Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018 149
Q3 2018 149
Q2 2018 148
Q1 2018 148
Q4 2017 148
Q3 2017 148
Q2 2017 147
Q1 2017 147
Q4 2016 148
Q3 2016 148
Q2 2016 148
Q1 2016 148
Q4 2015 149
Q3 2015 150
Q2 2015 149
Q1 2015 149
Q4 2014 149
Q3 2014 148
Q2 2014 149
Q1 2014 151
Q4 2013 140
Q3 2013 141
Q2 2013 139
Q1 2013 124
Q4 2012 134
Q3 2012 133
Q2 2012 133
Q1 2012 134
Q4 2011 139
Q3 2011 136
Q2 2011 142
Q1 2011 153
Q4 2010 143
Q3 2010 145
Q2 2010 141
Q1 2010 136
Q4 2009 137
Q3 2009 140
Q2 2009 139
Q1 2009 133
Q4 2008 134
Q3 2008 120
Q2 2008 133
Q1 2008 128
Q4 2007 108
Q3 2007 119
Q2 2007 116
Q1 2007 107
Q4 2006 98
Q3 2006 101
Q2 2006 95
Q1 2006 83
Q4 2005 80
Q3 2005 82
Q2 2005 80
Q1 2005 77
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $44.645B $3.333B
Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.111B 12.95
Gilead Sciences (GILD) United States $81.365B 10.36
Celgene (CELG) United States $61.751B 11.42
Vertex Pharmaceuticals (VRTX) United States $47.003B 62.96
Biogen (BIIB) United States $43.327B 8.39
Regeneron Pharmaceuticals (REGN) United States $43.164B 20.05
Alexion Pharmaceuticals (ALXN) United States $29.563B 18.32
Incyte (INCY) United States $18.431B 172.04
BioMarin Pharmaceutical (BMRN) United States $15.795B 0.00
Seattle Genetics (SGEN) United States $11.861B 0.00
Exact Sciences (EXAS) United States $11.200B 0.00
QIAGEN (QGEN) Netherlands $8.969B 29.68
Alnylam Pharmaceuticals (ALNY) United States $8.948B 0.00
Sarepta Therapeutics (SRPT) United States $8.478B 0.00
Bluebird Bio (BLUE) United States $8.035B 0.00
BeiGene (BGNE) Cayman Islands $7.487B 0.00
Bio-Techne Corp (TECH) United States $7.334B 49.41
Exelixis (EXEL) United States $6.963B 16.22
Guardant Health (GH) United States $6.606B 0.00
Moderna (MRNA) United States $6.383B 0.00
Amarin (AMRN) Ireland $5.654B 0.00
Alkermes (ALKS) Ireland $5.209B 0.00
Array BioPharma (ARRY) United States $5.001B 0.00
Horizon Pharma Public (HZNP) Ireland $4.956B 14.68
Galapagos (GLPG) Belgium $4.875B 0.00
Ascendis Pharma (ASND) Denmark $4.845B 0.00
Spark Therapeutics (ONCE) United States $4.310B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.983B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.768B 0.00
China Biologic Products (CBPO) China $3.457B 21.42
Blueprint Medicines (BPMC) United States $3.453B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.371B 0.00
Immunomedics (IMMU) United States $3.348B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.247B 0.00
Allogene Therapeutics (ALLO) United States $3.015B 0.00
Amicus Therapeutics (FOLD) United States $2.969B 0.00
Global Blood Therapeutics (GBT) United States $2.866B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.841B 0.00
Mirati Therapeutics (MRTX) United States $2.660B 0.00
Genomic Health (GHDX) United States $2.608B 66.68
Reata Pharmaceuticals (RETA) United States $2.592B 0.00
Repligen (RGEN) United States $2.591B 79.73
Ligand Pharmaceuticals (LGND) United States $2.517B 18.80
Emergent Biosolutions (EBS) United States $2.508B 20.94
Akcea Therapeutics (AKCA) United States $2.445B 0.00
Myriad Genetics (MYGN) United States $2.430B 24.75
UniQure (QURE) Netherlands $2.331B 0.00
Acceleron Pharma (XLRN) United States $2.320B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.283B 0.00
Halozyme Therapeutics (HALO) United States $2.281B 0.00
Insmed (INSM) United States $2.194B 0.00
Arena Pharmaceuticals (ARNA) United States $2.179B 0.00
REGENXBIO (RGNX) United States $2.108B 22.01
MyoKardia (MYOK) United States $2.091B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.042B 0.00
Medicines (MDCO) United States $1.976B 0.00
Denali Therapeutics (DNLI) United States $1.953B 0.00
AnaptysBio (ANAB) United States $1.885B 0.00
NeoGenomics (NEO) United States $1.830B 148.85
CRISPR Therapeutics AG (CRSP) Switzerland $1.787B 0.00
Myovant Sciences (MYOV) United Kingdom $1.697B 0.00
Atara Biotherapeutics (ATRA) United States $1.685B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.640B 0.00
Allakos (ALLK) United States $1.582B 0.00
Audentes Therapeutics (BOLD) United States $1.546B 0.00
Puma Biotechnology (PBYI) United States $1.519B 0.00
GOSSAMER BIO (GOSS) United States $1.456B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.425B 0.00
Innoviva (INVA) United States $1.389B 3.83
Aimmune Therapeutics (AIMT) United States $1.379B 0.00
WAVE Life Sciences (WVE) Singapore $1.371B 0.00
Rubius Therapeutics (RUBY) United States $1.332B 0.00
ALECTOR INC (ALEC) United States $1.326B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.300B 0.00
Cambrex (CBM) United States $1.290B 13.88
Apellis Pharmaceuticals (APLS) United States $1.223B 0.00
Clovis Oncology (CLVS) United States $1.218B 0.00
Lion Biotechnologies (IOVA) United States $1.166B 0.00
Editas Medicine (EDIT) United States $1.119B 0.00
Codexis (CDXS) United States $1.083B 0.00
Epizyme (EPZM) United States $1.052B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.044B 0.00
Fate Therapeutics (FATE) United States $1.037B 0.00
RA PHARMCTL INC (RARX) United States $1.021B 0.00
InflaRx (IFRX) Germany $1.007B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.984B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.982B 0.00
Coherus BioSciences (CHRS) United States $0.979B 0.00
Retrophin (RTRX) United States $0.942B 0.00
Sangamo Therapeutics (SGMO) United States $0.941B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.935B 37.79
Deciphera Pharmaceuticals (DCPH) United States $0.919B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.907B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.907B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.893B 0.00
Athenex (ATNX) United States $0.836B 0.00
Eidos Therapeutics (EIDX) United States $0.800B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.798B 0.00
Vericel (VCEL) United States $0.797B 0.00
Principia Biopharma (PRNB) United States $0.793B 0.00
ANI Pharmaceuticals (ANIP) United States $0.790B 14.46
Inotek Pharmaceuticals (RCKT) United States $0.755B 0.00
Intellia Therapeutics (NTLA) United States $0.736B 0.00
Cellectis (CLLS) France $0.735B 0.00
Cara Therapeutics (CARA) United States $0.722B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.711B 0.00
Revance Therapeutics (RVNC) United States $0.678B 0.00
Heska (HSKA) United States $0.661B 59.25
Magenta Therapeutics (MGTA) United States $0.659B 0.00
Sorrento Therapeutics (SRNE) United States $0.657B 0.00
Osiris Therapeutics (OSIR) United States $0.656B 0.00
Intra-Cellular Therapies (ITCI) United States $0.653B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.649B 0.00
Acorda Therapeutics (ACOR) United States $0.625B 8.10
Synthorx (THOR) United States $0.620B 0.00
Twist Bioscience (TWST) United States $0.616B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.602B 0.00
Viking Therapeutics (VKTX) United States $0.592B 0.00
Kura Oncology (KURA) United States $0.586B 0.00
ObsEva SA (OBSV) Switzerland $0.576B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.571B 0.00
G1 THERAPEUTICS (GTHX) United States $0.553B 0.00
Axsome Therapeutics (AXSM) United States $0.544B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.539B 0.00
Zealand Pharma (ZEAL) Denmark $0.537B 5.98
Stemline Therapeutics (STML) United States $0.532B 0.00
Arvinas (ARVN) United States $0.513B 0.00
Arcus Biosciences (RCUS) United States $0.500B 0.00
UROGEN PHARMA (URGN) United States $0.497B 0.00
Scholar Rock Holding (SRRK) United States $0.490B 0.00
MeiraGTx Holdings (MGTX) United States $0.490B 0.00
Cytokineticsorporated (CYTK) United States $0.485B 0.00
CytomX Therapeutics (CTMX) United States $0.485B 0.00
Zymeworks (ZYME) Canada $0.481B 0.00
Prothena (PRTA) Ireland $0.478B 0.00
Replimune (REPL) United States $0.478B 0.00
PDL BioPharma (PDLI) United States $0.473B 10.54
Dynavax Technologies (DVAX) United States $0.459B 0.00
Mesoblast (MESO) Australia $0.457B 0.00
Five Prime Therapeutics (FPRX) United States $0.447B 0.00
DBV Technologies (DBVT) France $0.443B 0.00
AVROBIO (AVRO) United States $0.426B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.420B 0.00
Anika Therapeutics (ANIK) United States $0.420B 15.88
Achillion Pharmaceuticals (ACHN) United States $0.411B 0.00
Senesco Technologies (ELOX) United States $0.411B 0.00
BeyondSpring (BYSI) United States $0.395B 0.00
Krystal Biotech (KRYS) United States $0.395B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.393B 0.00
Agenus (AGEN) United States $0.380B 0.00
XBiotech (XBIT) United States $0.379B 0.00
MannKind (MNKD) United States $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Solid Biosciences (SLDB) United States $0.368B 0.00
BioDelivery Sciences (BDSI) United States $0.360B 0.00
Abeona Therapeutics (ABEO) United States $0.360B 0.00
Inovio Pharmaceuticals (INO) United States $0.353B 0.00
Kadmon Holdings (KDMN) United States $0.350B 0.00
MediciNova (MNOV) United States $0.348B 0.00
Albireo Pharma (ALBO) United States $0.346B 0.00
Adverum Biotechnologies (ADVM) United States $0.342B 0.00
AC Immune SA (ACIU) Switzerland $0.341B 0.00
Kezar Life Sciences (KZR) United States $0.339B 0.00
Kindred Biosciences (KIN) United States $0.330B 0.00
STEALTH BIOTHER (MITO) United States $0.328B 0.00
UNITY Biotechnology (UBX) $0.328B 0.00
Urovant Sciences (UROV) United States $0.324B 0.00
OSMOTICA PHARM (OSMT) United States $0.322B 0.00
Gritstone Oncology (GRTS) United States $0.317B 0.00
Protagonist Therapeutics (PTGX) United States $0.308B 0.00
Aduro Biotech (ADRO) United States $0.307B 0.00
Constellation Pharmaceuticals (CNST) United States $0.306B 0.00
Geron (GERN) United States $0.306B 0.00
Cellular Biomedicine (CBMG) United States $0.302B 0.00
Syros Pharmaceuticals (SYRS) United States $0.299B 0.00
Gamida Cell (GMDA) Israel $0.291B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.285B 0.00
Merus (MRUS) Netherlands $0.284B 0.00
Enochian BioSciences (ENOB) United States $0.279B 0.00
Kala Pharmaceuticals (KALA) United States $0.269B 0.00
Evelo Biosciences (EVLO) United States $0.268B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.260B 0.00
Seres Therapeutics (MCRB) United States $0.260B 0.00
Strongbridge Biopharma (SBBP) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.247B 0.00
Verastem (VSTM) United States $0.246B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.241B 0.00
Avid Bioservices (CDMO) United States $0.239B 0.00
Kodiak Sciences (KOD) United States $0.237B 0.00
Cerecor (CERC) United States $0.235B 0.00
TOCAGEN INC (TOCA) United States $0.233B 0.00
Novavax (NVAX) United States $0.230B 0.00
ResTORbio (TORC) United States $0.229B 0.00
ChromaDex (CDXC) United States $0.228B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Spero Therapeutics (SPRO) United States $0.227B 0.00
Athersys (ATHX) United States $0.226B 0.00
Kamada (KMDA) Israel $0.225B 10.18
BioTime (BTX) United States $0.218B 0.00
Intec Pharma (NTEC) Israel $0.217B 0.00
LogicBio Therapeutics (LOGC) United States $0.216B 0.00
Mersana Therapeutics (MRSN) United States $0.214B 0.00
Celcuity (CELC) United States $0.212B 0.00
Axovant Sciences (AXGT) United Kingdom $0.212B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.209B 0.00
Celyad SA (CYAD) Belgium $0.202B 0.00
Arbutus Biopharma (ABUS) Canada $0.201B 0.00
CorMedix Inc (CRMD) United States $0.198B 0.00
Palatin Technologies (PTN) United States $0.196B 96.33
Pfenex (PFNX) United States $0.195B 0.00
Synlogic (SYBX) United States $0.193B 0.00
OvaScience (MLND) United States $0.187B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.185B 0.00
Compugen (CGEN) Israel $0.184B 0.00
VBI Vaccines (VBIV) United States $0.182B 0.00
Menlo Therapeutics (MNLO) United States $0.180B 0.00
Liquidia Technologies (LQDA) United States $0.169B 0.00
PHASEBIO PHARMA (PHAS) United States $0.168B 0.00
Anavex Life Sciences (AVXL) United States $0.162B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.159B 0.00
ADMA Biologics Inc (ADMA) United States $0.153B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
Cue Biopharma (CUE) United States $0.152B 0.00
Trevena (TRVN) United States $0.148B 0.00
Chiasma (CHMA) United States $0.147B 0.00
BioXcel Therapeutics (BTAI) United States $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.144B 0.00
Aptinyx (APTX) United States $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.140B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.137B 0.00
Cohbar (CWBR) United States $0.137B 0.00
NantKwest (NK) United States $0.132B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.130B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
Equillium (EQ) United States $0.122B 0.00
Unum Therapeutics (UMRX) United States $0.121B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.121B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.119B 0.00
VolitionRX (VNRX) Singapore $0.116B 0.00
Pluristem Therapeutics (PSTI) Israel $0.112B 0.00
XOMA (XOMA) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.105B 0.00
Fortress Biotech (FBIO) United States $0.103B 0.00
Selecta Biosciences (SELB) United States $0.102B 0.00
Mustang Bio (MBIO) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.100B 0.00
Neothetics (EVFM) United States $0.100B 0.00
ARAVIVE, INC (ARAV) United States $0.092B 0.00
Signal Genetics (MGEN) United States $0.092B 0.00
Cel-Sci (CVM) United States $0.089B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.089B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.089B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.089B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.088B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.087B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.086B 0.00
Provention Bio (PRVB) United States $0.086B 0.00
Orgenesis (ORGS) United States $0.085B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.083B 0.00
Cocrystal Pharma (COCP) United States $0.081B 90.00
AVEO Pharmaceuticals (AVEO) United States $0.080B 0.00
VTv Therapeutics (VTVT) United States $0.079B 0.00
INMUNE BIO INC (INMB) United States $0.079B 0.00
Oncobiologics (OTLK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.078B 0.00
Alimera Sciences (ALIM) United States $0.077B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.077B 0.00
Applied Genetic Technologies (AGTC) United States $0.076B 0.00
OVID THERAPEUTC (OVID) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.069B 0.00
NewLink Genetics (NLNK) United States $0.069B 0.00
AEterna Zentaris (AEZS) United States $0.069B 13.09
SESEN BIO, INC (SESN) United States $0.067B 0.00
Proteostasis Therapeutics (PTI) United States $0.067B 0.00
Proteon Therapeutics (PRTO) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
Eyenovia (EYEN) United States $0.063B 0.00
Curis (CRIS) United States $0.063B 0.00
Celldex Therapeutics (CLDX) United States $0.061B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Ophthotech (OPHT) United States $0.060B 0.00
Zosano Pharma (ZSAN) United States $0.058B 0.00
Vaccinex (VCNX) United States $0.057B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.056B 0.00
Alcobra (ARCT) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
ScPharmaceuticals (SCPH) United States $0.053B 0.00
ANCHIANO THERAP (ANCN) Israel $0.052B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.051B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
Clearside Biomedical (CLSD) United States $0.050B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
Evogene (EVGN) Israel $0.048B 0.00
Arsanis (XFOR) United States $0.047B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
Entera Bio (ENTX) Israel $0.043B 0.00
TRACON Pharmaceuticals (TCON) United States $0.042B 0.00
Leap Therapeutics (LPTX) United States $0.042B 0.00
Aptevo Therapeutics (APVO) United States $0.042B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.037B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Caladrius Biosciences (CLBS) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
OncoSec Medical (ONCS) United States $0.032B 0.00
Sophiris Bio (SPHS) United States $0.032B 0.00
Adial Pharmaceuticals (ADIL) United States $0.029B 0.00
Motif Bio Plc (MTFB) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
GTx (GTXI) United States $0.028B 0.00
Aileron Therapeutics (ALRN) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.026B 0.00
CytRx (CYTR) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Fibrocell Science Inc (FCSC) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Galena Biopharma (SLS) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Dare Bioscience (DARE) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Oragenics (OGEN) United States $0.018B 0.00
Apricus Biosciences (SEEL) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
RestorGenex (DFFN) United States $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 7.11
Alliqua BioMedical (ALQA) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Edge Therapeutics (PDSB) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Synthetic Biologics (SYN) United States $0.011B 0.00
Pulmatrix (PULM) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Histogenics (HSGX) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00